女性性别与胸主动脉腔内修复术后支架内晚期管腔狭窄增加相关
这项多中心回顾性研究分析了2011年7月至2019年7月间接受胸主动脉腔内修复术(TEVAR)且有至少1年随访CT血管造影的208例患者(94例女性,114例男性),中位随访822天。
要点
- 女性性别、术前高血压和左锁骨下动脉覆盖是支架内管腔狭窄的独立预测因素。
核心结论
- 女性性别是TEVAR术后支架内管腔狭窄的显著不可改变危险因素。
- 支架内管腔狭窄并非良性现象,与再次干预需求增加相关。
研究设计与样本
- 多中心医疗系统回顾性分析,纳入2011年7月至2019年7月接受TEVAR且有至少1年随访增强CT影像的患者。
- 共208例患者符合纳入标准(94例女性,114例男性),中位随访822天。
主要发现
- 小主动脉直径及同期使用抗血小板或抗凝药物未发现与支架内管腔狭窄独立相关。
临床怎么用
- TEVAR术后监测应考虑患者特异性并发症风险差异,尤其是女性患者。
- 对于女性、术前高血压或需覆盖左锁骨下动脉的患者,应加强支架内管腔狭窄的影像学监测。
- 发现支架内管腔狭窄>20%时,需警惕再次干预风险并密切随访。
局限性
- 回顾性研究设计。
- 样本量有限(208例)。
- 支架内管腔狭窄的机制(如主动脉顺应性差异或凝血通路性别差异)尚需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Luminal narrowing, suspected secondary to thrombus, occurs within stent grafts at an unclear incidence after thoracic endovascular aortic repair (TEVAR). The significance of this phenomenon has not been determined, nor have the risk factors for development of intragraft luminal narrowing. Small graft diameter is hypothesized to be a risk factor for the development of ingraft stenosis. METHODS: A retrospective analysis was performed of a multicenter healthcare system including all patients who underwent TEVAR between July 2011 and July 2019 with at least 1 year of subsequently available surveillance contrast-enhanced computed tomography imaging. Standard demographic, preoperative, intraoperative, and postoperative variables were collected. Measurements were obtained via direct off-line images from computed tomography scans. Patent intragraft diameters were compared with baseline and interval change values were normalized to time to follow-up. The primary outcome measure was annual rate of intragraft luminal narrowing. RESULTS: There were 208 patients who met the inclusion criteria (94 women, 114 men) with a median follow-up of 822 days. The mean annual rate of percent intragraft diameter reduction was 10.5 ± 7.7% for women and 7.6 ± 5.6% for men (P = .0026). Multivariate analysis demonstrated female gender (P = .0283), preoperative diagnosis of hypertension (P = .0449), and need for coverage of the left subclavian artery (P = .0328) were all significant predictors of intragraft luminal narrowing. Small aortic diameters were not found to be associated independently with ingraft luminal narrowing nor was the concomitant use of antiplatelet or anticoagulation medications. Significant amounts of ingraft luminal narrowing, defined as a greater than 20% intragraft diameter decrease, were associated with an increased need for any reintervention, including for malperfusion, endoleak, and symptomatic aneurysm (P = .0249). Kaplan-Meier estimates demonstrated a significant gender-associated difference in high rates of intragraft luminal narrowing (P = .00189). CONCLUSIONS: In this analysis, female gender is shown to be a significant nonmodifiable risk factor for intragraft luminal narrowing after TEVAR. The development of this phenomenon is not benign; as such, these findings were associated with an increased need for reintervention. This finding may be attributable to differences in aortic compliance or gender-associated differences in coagulation pathways and merits further investigation. Surveillance after thoracic stent grafting must account for patient-specific variations in complication risk.
引用
- Kuo MC, Meena RA, Ramos CR, et al. Female gender is associated with increased late luminal narrowing within the stent graft after thoracic endovascular aortic repair. J Vasc Surg. 2021. PMID: 34450242. doi:10.1016/j.jvs.2021.07.226
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。